Why is Jubilant Ingrevia Ltd falling/rising?

1 hour ago
share
Share Via
On 15 Apr, Jubilant Ingrevia Ltd's stock price surged by 3.35% to close at ₹663.00, reflecting a notable outperformance relative to its sector and benchmark indices despite some underlying challenges in its financial performance.

Strong Short-Term Momentum and Market Outperformance

Jubilant Ingrevia’s recent price action has been robust, with the stock appreciating 5.12% over the past week and an impressive 18.58% over the last month. These gains significantly outpace the Sensex’s respective returns of 0.71% and 4.76% during the same periods. The stock also touched an intraday high of ₹671.05, marking a 4.61% increase on the day, and outperformed its sector by 1.84%. Such momentum indicates renewed investor interest and confidence in the company’s near-term prospects.

The stock’s technical positioning supports this optimism, trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. This suggests a positive short- to medium-term trend, albeit with some caution warranted over the longer term.

Patience pays off here! This Micro Cap from Fertilizers sector has delivered steady gains quarter after quarter. Now proudly part of our Reliable Performers list.

  • - New Reliable Performer
  • - Steady quarterly gains
  • - Fertilizers consistency

Discover the Steady Winner →

Institutional Confidence and Valuation Appeal

One of the key drivers behind the stock’s rise is the strong institutional backing. With institutional holdings at 30.17%, these investors bring a level of analytical rigour and long-term perspective that often supports stock stability and growth. Notably, institutional stakes have increased by 1.15% over the previous quarter, signalling growing confidence in Jubilant Ingrevia’s fundamentals.

From a valuation standpoint, the company presents a compelling case. Its return on capital employed (ROCE) stands at a respectable 10.6%, and it maintains a low Debt to EBITDA ratio of 1.43 times, underscoring a strong ability to service debt. The stock trades at a discount relative to its peers’ historical valuations, with an enterprise value to capital employed ratio of 3. This fair valuation, combined with a PEG ratio of 1.2, suggests that the stock is reasonably priced given its profit growth of 33.2% over the past year, despite a marginal negative return of -0.38% during the same period.

Challenges Tempering Long-Term Outlook

However, the company’s longer-term growth trajectory presents some concerns. Over the last five years, net sales have declined at an annualised rate of -0.45%, while operating profit has contracted more sharply by -13.67%. Recent quarterly results also reflect a downturn, with profit before tax excluding other income falling by 21.1% and net profit after tax declining by 21.9% compared to the previous four-quarter average. Additionally, the company’s debtors turnover ratio is relatively low at 5.56 times, which may indicate slower collections and potential working capital inefficiencies.

These factors suggest that while the stock is currently benefiting from positive market sentiment and institutional support, investors should remain cautious about the sustainability of its earnings growth and operational performance in the longer term.

Jubilant Ingrev. or something better? Our SwitchER feature analyzes this Smallcap Specialty Chemicals stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Liquidity and Investor Participation

Liquidity remains adequate for trading, with the stock’s average traded value supporting trade sizes of approximately ₹0.24 crore. However, investor participation has shown signs of waning, as delivery volumes on 13 Apr dropped by 35.24% compared to the five-day average. This decline in active trading volume may reflect some hesitation among retail investors despite the stock’s recent gains.

In summary, Jubilant Ingrevia Ltd’s rise on 15-Apr is primarily driven by strong short-term price momentum, institutional buying, and attractive valuation metrics relative to peers. Nonetheless, the company’s subdued long-term sales growth and recent profit declines warrant a cautious approach. Investors should weigh these mixed signals carefully when considering the stock’s future potential.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News